NEW YORK, Oct. 26, 2023 (GLOBE NEWSWIRE) -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to:
POINT Biopharma Global, Inc. (NASDAQ:PNT)'s sale to Eli Lilly for $12.50 per share in cash. If you are a POINT Biopharma shareholder, click here to learn more about your rights and options.
Mirati Therapeutics, Inc. (NASDAQ:MRTX)'s sale to Bristol Myers Squibb for $58.00 per share in cash. Additionally, Mirati shareholders will also receive one non-tradeable Contingent Value Right per Mirati share, entitling its holder to receive a one-time potential payment of ...